These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21554270)

  • 1. Role of type 2 diabetes mellitus in nonalcoholic fatty liver disease.
    Filik L
    Eur J Clin Invest; 2011 Dec; 41(12):1367; author reply 1368. PubMed ID: 21554270
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
    Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Obesity--pacemaker of the metabolic syndrome].
    Knappe G
    Z Arztl Fortbild (Jena); 1992 Sep; 86(18):891-4. PubMed ID: 1413907
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.
    Kelley DE; McKolanis TM; Hegazi RA; Kuller LH; Kalhan SC
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E906-16. PubMed ID: 12959938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of obesity, metabolic syndrome, diabetes, and cardiovascular disease with nonalcoholic fatty liver disease.
    Bell DS
    South Med J; 2009 Oct; 102(10):991-2. PubMed ID: 19738529
    [No Abstract]   [Full Text] [Related]  

  • 6. MR fat fraction mapping: a simple biomarker for liver steatosis quantification in nonalcoholic fatty liver disease patients.
    Leitão HS; Paulino C; Rodrigues D; Gonçalves SI; Marques C; Carvalheiro M; Geraldes CF; Caseiro-Alves F
    Acad Radiol; 2013 Aug; 20(8):957-61. PubMed ID: 23830602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving trends in nonalcoholic fatty liver disease.
    Delgado JS
    Eur J Intern Med; 2008 Mar; 19(2):75-82. PubMed ID: 18249301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise and fat accumulation in the human liver.
    Magkos F
    Curr Opin Lipidol; 2010 Dec; 21(6):507-17. PubMed ID: 21206340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking.
    Mittendorfer B
    Curr Opin Clin Nutr Metab Care; 2011 Nov; 14(6):535-41. PubMed ID: 21849896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel insights into the pathophysiology of nonalcoholic fatty liver disease.
    Feldstein AE
    Semin Liver Dis; 2010 Nov; 30(4):391-401. PubMed ID: 20960378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between body fat and liver fat accumulation and cytokine pattern in non-alcoholic patients with chronic HCV infection.
    González-Reimers E; Castellano-Higuera A; Alemán-Valls R; Alvarez-Argüelles H; de la Vega-Prieto MJ; Abreu-González P; López-Prieto J; Santolaria-Fernández F; Valladares-Parrilla F
    Ann Nutr Metab; 2009; 55(4):351-7. PubMed ID: 19851063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of fatty liver in metabolic syndrome].
    Fodor M
    Orv Hetil; 2010 Aug; 151(35):1430-3. PubMed ID: 20719718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue as an endocrine organ.
    McGown C; Birerdinc A; Younossi ZM
    Clin Liver Dis; 2014 Feb; 18(1):41-58. PubMed ID: 24274864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
    Martínez-Clemente M; Clària J; Titos E
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis.
    Perseghin G
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S367-70. PubMed ID: 21525484
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatty liver: a novel component of the metabolic syndrome.
    Kotronen A; Yki-Järvinen H
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):27-38. PubMed ID: 17690317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.